Policy and Practice Reviews
Accepted on 19 Sep 2025
Early Access Disparities in Innovative Therapies Across the US, EU, China and Japan
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1642882
- 332 views
87 Publications
Volume 5 - 2025
Opinion
Published on 16 Sep 2025
Rethinking drug safety signal detection and causality assessment in the age of AI: the risks of incomplete data and biased insights
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1678074
- 1,554 views
Original Research
Published on 10 Sep 2025
Identifying regulatory outcomes of Non-interventional Post-Authorisation Safety Studies (PASS) in the European repository of studies using publicly available information
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1574430
- 1,301 views
Perspective
Accepted on 02 Sep 2025
Leveraging Real-World Data for Safety Signal Detection and Risk Management in Pre-and Post-Market Settings
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1626822
- 567 views
Mini Review
Accepted on 25 Aug 2025
Tokenization Techniques for Privacy-Preserving Healthcare Data: Tokenization Nuts and Bolts
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1599217
- 542 views
Perspective
Published on 15 Aug 2025
A national pharmacovigilance centre perspective on pandemic preparedness - lessons learned from the COVID-19 pandemic
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1644680
- 2,691 views
Clinical Trial
Published on 11 Aug 2025
Medication beliefs and adherence during and after pregnancy among women at risk for gestational hypertensive disorders
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1610273
- 1,030 views
Editorial
Published on 28 Jul 2025
Editorial: Safety of corticosteroids in respiratory medicine
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1656299
- 1,239 views
Review
Published on 20 Jun 2025
Centralized daily drug management in clinical trial institutions and specific implementation plans
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1620314
- 1,303 views
Methods
Published on 26 May 2025
Federated learning: a privacy-preserving approach to data-centric regulatory cooperation
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1579922
- 2,325 views
Review
Published on 24 Apr 2025
Corticosteroids in lung cancer
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1528468
- 3,177 views
Original Research
Published on 13 Mar 2025
Developing decision support algorithm for hypertension medications for use in a digital therapeutic system
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1476998
- 1,536 views
Editorial
Published on 11 Mar 2025
Editorial: External control arms for single-arm studies: methodological considerations and applications
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1579171
- 1,777 views
Perspective
Published on 13 Feb 2025
Implementing tokenization in clinical research to expand real-world insights
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1519307
- 3,419 views
Volume 4 - 2024
Review
Published on 17 Jan 2025
Integrating environmental effects in the benefit-risk assessment of therapeutic products: a proposal and example for sustainable health and healthcare
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1519142
- 2,503 views
- 1 citation
Original Research
Published on 16 Jan 2025
The safety and efficacy of neutral electrolyzed water solution for wound irrigation: post-market clinical follow-up study
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1402684
- 2,529 views
- 1 citation